(4) Changes in prescribing trends have been facilitated by a growing number of available GLP-1 receptor agonists, with currently ten agents approved for clinical use
Many ovarian cancer patients, especially those with obesity or type 2 diabetes, live in a hyperinsulinemic, pro-inflammatory state
The Comprehensive Metabolic Panel (CMP-14) , which is a common screening panel that checks for liver, metabolism, and kidney function along with fluid balance and other important health markers
Common GLP-1 side effects include nausea, constipation, and reduced appetite intensitytypically mild and temporary during dose escalation
If needed, use a larger sterile vial or split volume appropriately
This approach theoretically maintains more consistent medication levels and may reduce peak-dose side effects like nausea or stomach upset